GSK rejects Unilever offers for Consumer Healthcare

17 January 2022 - Deborah Wilkes


GlaxoSmithKline (GSK) has rejected three Unilever takeover offers for its Consumer Healthcare business, including one worth GBP50 billion (USD68 billion).

Click tags below for more information on topics:

GlaxoSmithKline Unilever

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: